O glycosylation of an Sp1-derived peptide blocks known Sp1 protein interactions

The O-linked N-acetylglucosamine (O-GlcNAc) modification of proteins is dynamic and abundant in the nucleus and cytosol. Several transcription factors, including Sp1, have been shown to contain this modification; however, the functional role of O-GlcNAc in these proteins has not been determined. In this paper we describe the use of the previously characterized glutamine-rich transactivation domain of Sp1 (B-c) as a model to investigate the role of O-GlcNAc in Sp1's transcriptionally relevant protein-to-protein interactions with the TATA-binding-protein-associated factor (TAF110) and holo-Sp1. When the model Sp1 peptide was overexpressed in primate cells, this 97-amino-acid domain of Sp1 was found to contain a dominant O-GlcNAc residue at high stoichiometry, which allowed the mapping and mutagenesis of this glycosylation site. In vitro interaction studies between this segment of Sp1 and Drosophila TAF110 or holo-Sp1 indicate that the O-GlcNAc modification functions to inhibit the largely hydrophobic interactions between these proteins. In HeLa cells, the mutation at the mapped glycosylation site was permissive for transcriptional activation. We propose the hypothesis that the removal of O-GlcNAc from an interaction domain can be a signal for protein association. O-GlcNAc may thereby prevent untimely and ectopic interactions.

[1]  Gerald M. Rubin,et al.  TAFIIs Mediate Activation of Transcription in the Drosophila Embryo , 1998, Cell.

[2]  I. Han,et al.  Reduced O glycosylation of Sp1 is associated with increased proteasome susceptibility , 1997, Molecular and cellular biology.

[3]  R. Tjian,et al.  DNA Template and Activator-Coactivator Requirements for Transcriptional Synergism by Drosophila Bicoid , 1995, Science.

[4]  G. Hart,et al.  c-Myc Is Glycosylated at Threonine 58, a Known Phosphorylation Site and a Mutational Hot Spot in Lymphomas (*) , 1995, The Journal of Biological Chemistry.

[5]  Aaron Ciechanover,et al.  The ubiquitin-proteasome proteolytic pathway , 1994, Cell.

[6]  G. Hart,et al.  Purification and characterization of an O-GlcNAc selective N-acetyl-beta-D-glucosaminidase from rat spleen cytosol. , 1994, The Journal of biological chemistry.

[7]  T. Shin,et al.  Identification and characterization of the human transforming growth factor-alpha initiator. , 1994, Molecular endocrinology.

[8]  M. Montminy,et al.  The cAMP-regulated transcription factor CREB interacts with a component of the TFIID complex. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[9]  R. Tjian,et al.  A glutamine-rich hydrophobic patch in transcription factor Sp1 contacts the dTAFII110 component of the Drosophila TFIID complex and mediates transcriptional activation. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[10]  R. Tjian,et al.  Drosophila TAFII40 interacts with both a VP16 activation domain and the basal transcription factor TFIIB , 1993, Cell.

[11]  W. G. Kelly,et al.  RNA polymerase II is a glycoprotein. Modification of the COOH-terminal domain by O-GlcNAc. , 1993, The Journal of biological chemistry.

[12]  R. Tjian,et al.  Molecular cloning and functional analysis of Drosophila TAF110 reveal properties expected of coactivators , 1993, Cell.

[13]  W. G. Kelly,et al.  Localization of O-GlcNAc modification on the serum response transcription factor. , 1992, The Journal of biological chemistry.

[14]  R. Tjian,et al.  Coactivators for a proline-rich activator purified from the multisubunit human TFIID complex. , 1991, Genes & development.

[15]  R. Tjian,et al.  Transcription from a TATA-less promoter requires a multisubunit TFIID complex. , 1991, Genes & development.

[16]  R. Tjian,et al.  Different activation domains of Sp1 govern formation of multimers and mediate transcriptional synergism. , 1991, Genes & development.

[17]  B. Moss,et al.  Vaccinia virus: a tool for research and vaccine development , 1991, Science.

[18]  G. Hart,et al.  Lymphocyte activation induces rapid changes in nuclear and cytoplasmic glycoproteins. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[19]  W. D. Cress,et al.  Critical structural elements of the VP16 transcriptional activation domain. , 1991, Science.

[20]  R. Tjian,et al.  GC box binding induces phosphorylation of Sp1 by a DNA-dependent protein kinase , 1990, Cell.

[21]  J. Hanover,et al.  Glycosylation of nuclear pore protein p62. Reticulocyte lysate catalyzes O-linked N-acetylglucosamine addition in vitro. , 1990, The Journal of biological chemistry.

[22]  R. Tjian,et al.  Synergistic activation by the glutamine-rich domains of human transcription factor Sp1 , 1989, Cell.

[23]  R. Tjian,et al.  Distinct regions of Sp1 modulate DNA binding and transcriptional activation. , 1988, Science.

[24]  R. Tjian,et al.  Analysis of Sp1 in vivo reveals mutiple transcriptional domains, including a novel glutamine-rich activation motif , 1988, Cell.

[25]  R. Tjian,et al.  O-glycosylation of eukaryotic transcription factors: Implications for mechanisms of transcriptional regulation , 1988, Cell.

[26]  Mark Ptashne,et al.  Negative effect of the transcriptional activator GAL4 , 1988, Nature.

[27]  G. Hart,et al.  Nuclear pore complex glycoproteins contain cytoplasmically disposed O- linked N-acetylglucosamine , 1987, The Journal of cell biology.

[28]  M. Schindler,et al.  A nuclear specific glycoprotein representative of a unique pattern of glycosylation. , 1987, The Journal of biological chemistry.

[29]  G. Hart,et al.  The subcellular distribution of terminal N-acetylglucosamine moieties. Localization of a novel protein-saccharide linkage, O-linked GlcNAc. , 1986, The Journal of biological chemistry.

[30]  W. G. Kelly,et al.  Glycosylation of Nuclear and Cytoplasmic Proteins Is as Abundant and as Dynamic as Phosphorylation , 1994 .

[31]  W. G. Kelly,et al.  Glycosylation in the nucleus and cytoplasm. , 1989, Annual review of biochemistry.